anti-BCL2-Like 2 (BCL2L2) Antibodies

BCL2L2 encodes a member of the BCL-2 protein family. Additionally we are shipping BCL2-Like 2 Proteins (18) and BCL2-Like 2 Kits (11) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
BCL2L2 599 Q92843
BCL2L2 12050 P70345
BCL2L2 60434  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-BCL2-Like 2 Antibodies at

Showing 10 out of 124 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Cow Rabbit Un-conjugated WB WB Suggested Anti-Bcl2l2 AntibodyTitration: 1.0 µg/mL <br /> Positive Control: Mouse Testis 100 μL Log in to see 2 to 3 Days
Human Rabbit Un-conjugated IHC (p), WB Western blot analysis of anti-Bcl-w BH3 domain Pab (ABIN388097) in HL-60 cell lysate. Bcl-w BH3 domain (arrow) was detected using purified polyclonal antibody. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. Western blot analysis of Bcl-w3 (arrow) using rabbit polyclonal Bcl-w BH3 Domain Antibody (ABIN388097). 293 cell lysates (2 µg/lane) either nontransfected (Lane 1) or transiently transfected with the BCL2L2 gene (Lane 2) (Origene Technologies). 400 μL Log in to see 10 to 11 Days
Cow Rabbit Un-conjugated IC, IF, IHC, WB Immunofluorescent analysis of BCLW staining in HL60 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Immunohistochemical analysis of BCLW staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. 200 μL Log in to see 13 to 14 Days
Human Rabbit Un-conjugated IF, ELISA, WB Western blot analysis of extracts from COLO cells, using BCLW Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of HepG2 cells, using BCLW Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Log in to see 2 to 3 Days
Human Rat Un-conjugated WB Western blot analysis for Bcl-w. Lysates from mouse brain tissue were probed with the rat anti- Bcl-w antibody at concentrations of 0.5 µg/mL (lane 1), 0.25 µg/mL (lane 2), and 0.125 µg/mL (lane 3). Bcl-w may be observed to be migrating in a range from 21-25 kDa. 50 μg Log in to see 6 to 8 Days
Human Rabbit Un-conjugated EIA, IHC (p), WB   0.1 mg Log in to see 12 to 15 Days
Human Rabbit Un-conjugated IHC (p), WB Anti- BCL2L2 antibody, IHC(P) IHC(P): Human Rectal Cancer Tissue Anti- BCL2L2 antibody,  Western blotting All lanes: Anti BCL2L2 () at 0.5ug/ml WB: HELAWhole Cell Lysate at 40ug Predicted bind size: 21KD Observed bind size: 21KD 100 μg Log in to see 4 to 6 Days
Human Rabbit Un-conjugated IHC, WB 100 μL Log in to see 16 Days
Human Rabbit Un-conjugated ICC, IF, IHC, WB Western Blot: BCL-W/BCL2L2 Antibody [NBP1-19705] - Analysis of Bcl-w (G154) antibody in extracts from COLO cells. 0.1 mL Log in to see 7 to 9 Days
Human Rabbit Un-conjugated ICC, IHC, WB Figure.DAB staining on IHC-P. Samples: Human Tissue 100 μg Log in to see 13 to 16 Days

BCL2L2 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, , ,
, , , , , , , , , , , , , , , , ,
Mouse (Murine) , , ,
, , ,
, , , , , , , , , , , , , , , ,
Rat (Rattus) , ,
, ,
, , , , , , , , , , , , ,

Top referenced anti-BCL2-Like 2 Antibodies

  1. Human Monoclonal BCL2L2 Primary Antibody for WB - ABIN967292 : Adams, Cory: The Bcl-2 protein family: arbiters of cell survival. in Science (New York, N.Y.) 1998 (PubMed)
    Show all 5 Pubmed References

More Antibodies against BCL2-Like 2 Interaction Partners

Human BCL2-Like 2 (BCL2L2) interaction partners

  1. BCL-W contributes to the threshold of anti-apoptotic activity during mitosis

  2. we demonstrated that miR (show MLXIP Antibodies)-126-5p plays an inhibitory role in human cervical cancer progression, regulating the apoptosis of cancer cells via directly targeting Bcl2l2.

  3. High expression of Bcl-w was associated with mesenchymal changes and invading populations in the glioblastoma multiforme; Bcl-w functions as a positive regulator of invasion by enhancing mesenchymal traits of glioblastoma multiforme, consequently contributing to malignancy.

  4. BCL2L2 was the virtual target of miR (show MLXIP Antibodies)-133b, and we found a negative regulatory relationship between miR (show MLXIP Antibodies)-133b and BCL2L2. MiR (show MLXIP Antibodies)-133b and BCL2L2 interfered with the viability and apoptosis of cells.

  5. overexpression of miR (show MLXIP Antibodies)-15a in the FaDu cells was associated with significantly decreased BCL2L2 and BCL2 (show BCL2 Antibodies) expression and a significant increase in the apoptosis rate. The opposite results were observed in HPV-positive HSCC, where downregulation of miR (show MLXIP Antibodies)-15a suppressed apoptosis

  6. we conclude that BER treatment reduces cisplatin resistance of gastric cancer cells by modulating the miR (show MLXIP Antibodies)-203/Bcl-w apoptotic axis. BER may be a novel agent to enhance chemotherapeutic responses in cisplatin-resistant gastric cancer patients

  7. Genetic and pharmacological inhibition of BCL-W and BCL-XL (show BCL2L1 Antibodies) causes directed elimination of senescent cells.

  8. Data show that BCL2-like 2 protein (BCL2L2) is a direct target of micrRNA miR (show MLXIP Antibodies)-29b.

  9. these results indicate that miR (show MLXIP Antibodies)-335 acts as a novel tumor suppressor to regulate ccRCC cell proliferation and invasion through downregulation of BCL-W expression.

  10. miR (show MLXIP Antibodies)-15a acts as a tumor suppressor in NSCLC by directly targeting BCL2L2 and may serve as a potential diagnostic biomarker and therapeutic target for NSCLC.

Mouse (Murine) BCL2-Like 2 (BCL2L2) interaction partners

  1. MYC (show MYC Antibodies) regulates BCL-W expression through its transcriptional regulation of specific miR (show MLXIP Antibodies).

  2. Genetic and pharmacological inhibition of BCL-W and BCL-XL (show BCL2L1 Antibodies) causes directed elimination of senescent cells.

  3. NF-kappaB (show NFKB1 Antibodies) p65 (show NFkBP65 Antibodies)/p52 (show GTF2H4 Antibodies) signaling mediated the effects of GDNF on Bcl-2 (show BCL2 Antibodies) and Bcl-w expressions

  4. Target-derived neurotrophins coordinate transcription of the antiapoptotic gene bclw with transport of bclw mRNA to the axon, and thereby prevent axonal degeneration in rat and mouse sensory neurons.

  5. By using human cancer cells and mouse embryonic fibroblasts, the study shows that Bcl-w functions in the mitochondria to increase the levels of reactive oxygen species (ROS (show ROS1 Antibodies)), which subsequently stimulates the invasion-promoting signaling pathway.

  6. Bcl-2 (show BCL2 Antibodies), Bcl-x(L (show BCL2L1 Antibodies)) and Bcl-w have only minor roles in thymic lymphoma development elicited by defects in p53 (show TP53 Antibodies), and this may indicate that Mcl-1 (show MCL1 Antibodies) and/or A1 may feature more prominently in this process.

  7. Induction of autocrine Bcl-w signaling through pericytes promoting endothelial cell survival is associated with melanoma development.

  8. Bcl-w(-/-) sensory neurons exhibit mitochondrial abnormalities, including alterations in axonal mitochondrial size, axonal mitochondrial membrane potential, and cellular ATP levels.

  9. Bcl-x(L) and Bcl-w target protein phosphatase 1alpha to Bad

  10. Bcl-2 (show BCL2 Antibodies), Bcl-w, and Bax (show BAX Antibodies) act in a redundant manner in regulating granulocyte survival and death

Cow (Bovine) BCL2-Like 2 (BCL2L2) interaction partners

  1. Chromosome mapping of BCL2L2 gene in cows.

BCL2-Like 2 (BCL2L2) Antigen Profile

Protein Summary

This gene encodes a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators. Expression of this gene in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream PABPN1 (poly(A) binding protein, nuclear 1) gene.

Gene names and symbols associated with anti-BCL2-Like 2 (BCL2L2) Antibodies

  • BCL2-like 2 (bcl2l2) antibody
  • BCL2 like 2 (BCL2L2) antibody
  • BCL2-like 2 (Bcl2l2) antibody
  • Bcl2-like 2 (Bcl2l2) antibody
  • AW048834 antibody
  • Bcl-w antibody
  • BCL-WEL antibody
  • BCL-WS antibody
  • BCL2-L-2 antibody
  • BCL2L2 antibody
  • Bclw antibody
  • c98 antibody
  • Gtrgal2 antibody
  • Gtrosa41 antibody
  • PPP1R51 antibody

Protein level used designations for anti-BCL2-Like 2 (BCL2L2) Antibodies

Bcl2-like 2 , BCL2-like 2 , apoptosis regulator BCL-W , bcl-2-like protein 2 , protein phosphatase 1, regulatory subunit 51 , apoptosis regulator Bcl-W , bcl2-L-2

496475 Xenopus (Silurana) tropicalis
768265 Felis catus
599 Homo sapiens
12050 Mus musculus
490611 Canis lupus familiaris
60434 Rattus norvegicus
767601 Bos taurus
Selected quality suppliers for anti-BCL2-Like 2 (BCL2L2) Antibodies
Did you look for something else?